NextGen Healthcare Stock Forecast, Price & News

NextGen Healthcare's stock was trading at $11.01 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, NXGN stock has increased by 28.3% and is now trading at $14.13.
View which stocks have been most impacted by COVID-19.

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for NextGen Healthcare in the last year. There are currently 1 sell rating, 8 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for NextGen Healthcare.

NextGen Healthcare is scheduled to release its next quarterly earnings announcement on Thursday, January 28th 2021.
View our earnings forecast for NextGen Healthcare.

NextGen Healthcare, Inc. (NASDAQ:NXGN) posted its quarterly earnings data on Thursday, October, 22nd. The company reported $0.30 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.20 by $0.10. The firm earned $140 million during the quarter, compared to analyst estimates of $133.04 million. NextGen Healthcare had a return on equity of 10.60% and a net margin of 1.01%. The company's revenue for the quarter was up 4.3% on a year-over-year basis. During the same period last year, the company posted $0.24 EPS.
View NextGen Healthcare's earnings history.

NextGen Healthcare updated its FY21 earnings guidance on Thursday, October, 22nd. The company provided earnings per share (EPS) guidance of $0.83-0.93 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.79. The company issued revenue guidance of $535-551 million, compared to the consensus revenue estimate of $539.99 million.

11 brokers have issued 1 year price objectives for NextGen Healthcare's shares. Their forecasts range from $10.00 to $21.00. On average, they expect NextGen Healthcare's stock price to reach $12.95 in the next year. This suggests that the stock has a possible downside of 8.3%.
View analysts' price targets for NextGen Healthcare.

NextGen Healthcare saw a increase in short interest in September. As of September 30th, there was short interest totaling 1,630,000 shares, an increase of 23.5% from the September 15th total of 1,320,000 shares. Based on an average daily volume of 312,400 shares, the short-interest ratio is currently 5.2 days. Approximately 3.0% of the shares of the company are short sold.
View NextGen Healthcare's Short Interest.

Some companies that are related to NextGen Healthcare include Verint Systems (VRNT), Parsons (PSN), Scientific Games (SGMS), Allscripts Healthcare Solutions (MDRX), NetScout Systems (NTCT), Sykes Enterprises (SYKE), Simulations Plus (SLP), OneSpan (OSPN), Unisys (UIS), Agilysys (AGYS), Ebix (EBIX), Ribbon Communications (RBBN), Digimarc (DMRC), Tufin Software Technologies (TUFN) and Asure Software (ASUR).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other NextGen Healthcare investors own include Altria Group (MO), Verizon Communications (VZ), Exxon Mobil (XOM), Best Buy (BBY), Enbridge (ENB), Enterprise Products Partners (EPD), Huntington Bancshares (HBAN), Netflix (NFLX), Tapestry (TPR) and Twitter (TWTR).

NextGen Healthcare trades on the NASDAQ under the ticker symbol "NXGN."

NextGen Healthcare's stock is owned by many different institutional and retail investors. Top institutional investors include Smith Graham & Co. Investment Advisors LP (1.38%), Paradigm Capital Management Inc. NY (0.87%), Assenagon Asset Management S.A. (0.60%), Foundry Partners LLC (0.55%), State of Alaska Department of Revenue (0.08%) and Louisiana State Employees Retirement System (0.04%). Company insiders that own NextGen Healthcare stock include George H Bristol, James Robert Jr Arnold, Jeffrey D Linton, Jeffrey H Margolis, Lance Rosenzweig and Sheldon Razin.
View institutional ownership trends for NextGen Healthcare.

NXGN stock was sold by a variety of institutional investors in the last quarter, including Paradigm Capital Management Inc. NY, Smith Graham & Co. Investment Advisors LP, and Foundry Partners LLC.
View insider buying and selling activity for NextGen Healthcare.

NXGN stock was acquired by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Bowling Portfolio Management LLC, Louisiana State Employees Retirement System, State of Alaska Department of Revenue, Nisa Investment Advisors LLC, and Diversified Trust Co. Company insiders that have bought NextGen Healthcare stock in the last two years include James Robert Jr Arnold, Jeffrey D Linton, and Jeffrey H Margolis.
View insider buying and selling activity for NextGen Healthcare.

Shares of NXGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of NXGN stock can currently be purchased for approximately $14.13.

NextGen Healthcare has a market capitalization of $942.03 million and generates $540.24 million in revenue each year. The company earns $7.50 million in net income (profit) each year or $0.59 on an earnings per share basis. NextGen Healthcare employs 2,754 workers across the globe.

The official website for NextGen Healthcare is www.nextgen.com.

NextGen Healthcare's mailing address is 18111 Von Karman Avenue Suite 800, Irvine CA, 92612. The company can be reached via phone at 949-255-2600 or via email at [email protected]